Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SCD | O00767 | 12/20 | 0.53 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.47 |
| ▸ | LMNA | P02545 | 2/20 | 0.47 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.47 |
| ▸ | HTT | P42858 | 1/20 | 0.46 |
| ▸ | DCTPP1 | Q9H773 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4778897 | 1.00 | SCD (0.53) | SCDKDM4ELMNASMN1; SMN2HTT | |
| SCHEMBL14261415 | 0.94 | SCD (0.53) | SCDKDM4ELMNASMN1; SMN2HTT | |
| SCHEMBL4780130 | 0.91 | SCD (0.52) | SCDKDM4ELMNASMN1; SMN2HTT | |
| SCHEMBL4781009 | 0.91 | SCD (0.52) | SCDKDM4ELMNASMN1; SMN2HTT | |
| SCHEMBL14261331 | 0.90 | SCD (0.52) | SCDKDM4ELMNASMN1; SMN2HTT | |
| SCHEMBL14261405 | 0.87 | ALDH1A1 (0.54) | KDM4ELMNASMN1; SMN2HTT | |
| SCHEMBL14261408 | 0.87 | SCD (0.51) | SCDKDM4ELMNASMN1; SMN2HTT | |
| SCHEMBL14261642 | 0.87 | CALML3 (0.43) | SCDKDM4ELMNASMN1; SMN2HTT | |
| SCHEMBL4783924 | 0.87 | SCD (0.51) | SCDKDM4ELMNASMN1; SMN2HTT | |
| SCHEMBL4727825 | 0.87 | CALML3 (0.43) | SCDKDM4ELMNASMN1; SMN2HTT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2008029266-A1 | STEAROYL COA DESATURASE INHIBITORS | GLENMARK PHARMACEUTICALS S.A. (US) | 2008-03-13 | — | — | WO | claimed |
| WO-2008029266-A1 | STEAROYL COA DESATURASE INHIBITORS | GLENMARK PHARMACEUTICALS S.A. (US) | 2008-03-13 | — | — | WO | disclosed |